US Patent Issued to CSPC MEGALITH BIOPHARMACEUTICAL on Sept. 1 for "Nectin-4 antibodies and uses thereof" (Pennsylvania, New Jersey, California Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,100, issued on Sept. 1, was assigned to CSPC MEGALITH BIOPHARMACEUTICAL Co. LTD. (Shijiazhuang, China).

"Nectin-4 antibodies and uses thereof" was invented by Yi Pei (Paoli, Pa.), Haichun Huang (Fremont, Calif.), Ming Lei (Princeton, N.J.) and Han Li (Newton, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides antibodies and antibody fragments thereof that bind to Nectin-4. Such antibodies and antibody fragments are useful for the treatment of cancer, either alone or in combination with other agents."

The patent was filed on Sept. 3, 2021, under Application No. 18/024,465.

*For further information, including images, ...